[Antiplatelet therapy after coronary stenting and its importance in total joint arthroplasty].

N Harrasser; T Harnoss; F Brettner; F Liska; Matthias Pauschinger

doi:10.1007/s00132-012-1900-4

[Antiplatelet therapy after coronary stenting and its importance in total joint arthroplasty].

N Harrasser, T Harnoss, F Brettner, F Liska, Matthias Pauschinger

Department of Internal Medicine VIII, Division of Cardiology

Research output: Contribution to journal › Review article › peer-review

2 Citations (Web of Science)

Original language	German
Pages (from-to)	477-481
Journal	ORTHOPÄDE
Volume	41
Issue number	6
DOIs	https://doi.org/10.1007/s00132-012-1900-4
Publication status	Published - 2012

Keywords

NONCARDIAC SURGERY
ARTERY STENTS
BLOOD-LOSS
DISCONTINUATION
INTERVENTION
ASSOCIATION
CLOPIDOGREL
PREVENTION
GUIDELINES
MANAGEMENT

Access to Document

10.1007/s00132-012-1900-4

Cite this

Harrasser, N., Harnoss, T., Brettner, F., Liska, F., & Pauschinger, M. (2012). [Antiplatelet therapy after coronary stenting and its importance in total joint arthroplasty]. ORTHOPÄDE , 41(6), 477-481. https://doi.org/10.1007/s00132-012-1900-4

Harrasser, N ; Harnoss, T ; Brettner, F et al. / [Antiplatelet therapy after coronary stenting and its importance in total joint arthroplasty]. In: ORTHOPÄDE 2012 ; Vol. 41, No. 6. pp. 477-481.

@article{1587f3c82b0a40b0b6eefa299bba0969,

title = "[Antiplatelet therapy after coronary stenting and its importance in total joint arthroplasty].",

keywords = "NONCARDIAC SURGERY, ARTERY STENTS, BLOOD-LOSS, DISCONTINUATION, INTERVENTION, ASSOCIATION, CLOPIDOGREL, PREVENTION, GUIDELINES, MANAGEMENT",

author = "N Harrasser and T Harnoss and F Brettner and F Liska and Matthias Pauschinger",

year = "2012",

doi = "10.1007/s00132-012-1900-4",

language = "Deutsch",

volume = "41",

pages = "477--481",

journal = "ORTHOP{\"A}DE ",

issn = "0085-4530",

publisher = "Springer Verlag",

number = "6",

}

Harrasser, N, Harnoss, T, Brettner, F, Liska, F & Pauschinger, M 2012, '[Antiplatelet therapy after coronary stenting and its importance in total joint arthroplasty].', ORTHOPÄDE , vol. 41, no. 6, pp. 477-481. https://doi.org/10.1007/s00132-012-1900-4

[Antiplatelet therapy after coronary stenting and its importance in total joint arthroplasty]. / Harrasser, N; Harnoss, T; Brettner, F et al.
In: ORTHOPÄDE , Vol. 41, No. 6, 2012, p. 477-481.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - [Antiplatelet therapy after coronary stenting and its importance in total joint arthroplasty].

AU - Harrasser, N

AU - Harnoss, T

AU - Brettner, F

AU - Liska, F

AU - Pauschinger, Matthias

PY - 2012

Y1 - 2012

KW - NONCARDIAC SURGERY

KW - ARTERY STENTS

KW - BLOOD-LOSS

KW - DISCONTINUATION

KW - INTERVENTION

KW - ASSOCIATION

KW - CLOPIDOGREL

KW - PREVENTION

KW - GUIDELINES

KW - MANAGEMENT

U2 - 10.1007/s00132-012-1900-4

DO - 10.1007/s00132-012-1900-4

M3 - Übersichtsarbeit

C2 - 22638598

SN - 0085-4530

VL - 41

SP - 477

EP - 481

JO - ORTHOPÄDE

JF - ORTHOPÄDE

IS - 6

ER -

Harrasser N, Harnoss T, Brettner F, Liska F, Pauschinger M. [Antiplatelet therapy after coronary stenting and its importance in total joint arthroplasty]. ORTHOPÄDE . 2012;41(6):477-481. doi: 10.1007/s00132-012-1900-4